Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 410

1.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006103. doi: 10.1002/14651858.CD006103.pub3. Review. Update in: Cochrane Database Syst Rev. 2010;(12):CD006103.

PMID:
18646137
2.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
3.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
4.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2012 Apr 18;4:CD006103. doi: 10.1002/14651858.CD006103.pub6. Review.

PMID:
22513936
5.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006103. Review. Update in: Cochrane Database Syst Rev. 2008;(3):CD006103.

PMID:
17253581
6.

Pharmacological interventions for smoking cessation: an overview and network meta-analysis.

Cahill K, Stevens S, Perera R, Lancaster T.

Cochrane Database Syst Rev. 2013 May 31;5:CD009329. doi: 10.1002/14651858.CD009329.pub2. Review.

PMID:
23728690
7.

What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.

Leaviss J, Sullivan W, Ren S, Everson-Hock E, Stevenson M, Stevens JW, Strong M, Cantrell A.

Health Technol Assess. 2014 May;18(33):1-120. doi: 10.3310/hta18330. Review.

8.

Interventions for smoking cessation and reduction in individuals with schizophrenia.

Tsoi DT, Porwal M, Webster AC.

Cochrane Database Syst Rev. 2013 Feb 28;2:CD007253. doi: 10.1002/14651858.CD007253.pub3. Review.

PMID:
23450574
9.

Nicotine replacement therapy for smoking cessation.

Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD000146. doi: 10.1002/14651858.CD000146.pub4. Review.

PMID:
23152200
10.

Interventions for preventing weight gain after smoking cessation.

Farley AC, Hajek P, Lycett D, Aveyard P.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD006219. doi: 10.1002/14651858.CD006219.pub3. Review.

PMID:
22258966
11.

Antidepressants for smoking cessation.

Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T.

Cochrane Database Syst Rev. 2014 Jan 8;1:CD000031. doi: 10.1002/14651858.CD000031.pub4. Review.

PMID:
24402784
12.

Nicotine vaccines for smoking cessation.

Hartmann-Boyce J, Cahill K, Hatsukami D, Cornuz J.

Cochrane Database Syst Rev. 2012 Aug 15;8:CD007072. doi: 10.1002/14651858.CD007072.pub2. Review.

PMID:
22895958
13.

Interventions for preventing weight gain after smoking cessation.

Parsons AC, Shraim M, Inglis J, Aveyard P, Hajek P.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006219. doi: 10.1002/14651858.CD006219.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;1:CD006219.

PMID:
19160269
14.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
15.

Nicotine replacement therapy for smoking cessation.

Stead LF, Perera R, Bullen C, Mant D, Lancaster T.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD000146. doi: 10.1002/14651858.CD000146.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD000146.

PMID:
18253970
16.

A preliminary benefit-risk assessment of varenicline in smoking cessation.

Cahill K, Stead L, Lancaster T.

Drug Saf. 2009;32(2):119-35. doi: 10.2165/00002018-200932020-00005. Review.

PMID:
19236119
17.

Electronic cigarettes for smoking cessation and reduction.

McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P.

Cochrane Database Syst Rev. 2014;12:CD010216. doi: 10.1002/14651858.CD010216.pub2. Epub 2014 Dec 17. Review.

PMID:
25515689
18.

Cannabinoid type 1 receptor antagonists for smoking cessation.

Cahill K, Ussher MH.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD005353. doi: 10.1002/14651858.CD005353.pub4. Review.

PMID:
21412887
19.

Smoking cessation interventions for smokers with current or past depression.

van der Meer RM, Willemsen MC, Smit F, Cuijpers P.

Cochrane Database Syst Rev. 2013 Aug 21;8:CD006102. doi: 10.1002/14651858.CD006102.pub2. Review.

PMID:
23963776
20.

Antidepressants for smoking cessation.

Hughes JR, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD000031. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD000031.

PMID:
17253443
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk